000 | 01412 a2200409 4500 | ||
---|---|---|---|
005 | 20250514050516.0 | ||
264 | 0 | _c20021114 | |
008 | 200211s 0 0 eng d | ||
022 | _a0028-3878 | ||
024 | 7 |
_a10.1212/wnl.59.8.1210 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSandrini, G | |
245 | 0 | 0 |
_aEletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. _h[electronic resource] |
260 |
_bNeurology _cOct 2002 |
||
300 |
_a1210-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xadverse effects |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
650 | 0 | 4 |
_aPyrrolidines _xadverse effects |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 |
_aSerotonin Receptor Agonists _xadverse effects |
650 | 0 | 4 |
_aSumatriptan _xadverse effects |
650 | 0 | 4 | _aTryptamines |
700 | 1 | _aFärkkilä, M | |
700 | 1 | _aBurgess, G | |
700 | 1 | _aForster, E | |
700 | 1 | _aHaughie, S | |
773 | 0 |
_tNeurology _gvol. 59 _gno. 8 _gp. 1210-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.59.8.1210 _zAvailable from publisher's website |
999 |
_c12200311 _d12200311 |